New YorkEnacts the manufacturer disclosure and transparency act
What it does
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jan 7REFERRED TO CONSUMER AFFAIRS AND PROTECTIONLatest
- 2025
- May 22PRINT NUMBER 2289AMajor
- May 22AMEND AND RECOMMIT TO CONSUMER AFFAIRS AND PROTECTIONMajor
- Jan 16REFERRED TO CONSUMER AFFAIRS AND PROTECTIONIntroduced